RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 111-121
  • Japanese firm Otsuka to buy Avanir Pharmaceuticals for $3.5 billion

    The merger wave sweeping the healthcare business caught up another Southern California company Tuesday as Avanir Pharmaceuticals Inc. in Aliso Viejo agreed to be acquired for about $3.5 billion in cash. Japanese drug giant Otsuka Pharmaceutical Co.,...
  • Japanese firm to buy Avanir Pharmaceuticals for $3.5 billion

    Japanese firm to buy Avanir Pharmaceuticals for $3.5 billion
    Avanir Pharmaceuticals Inc. in Aliso Viejo said Tuesday that it has agreed to be acquired by Japanese drug giant Otsuka Pharmaceutical Co. for about $3.5 billion in cash, the latest in a string of mergers sweeping the healthcare sector. Otsuka, a unit...
  • Los Angeles seafood company ordered shut over unsanitary conditions

    Los Angeles seafood company ordered shut over unsanitary conditions
    A Los Angeles seafood company specializing in smoked and pickled fish was ordered shut by a federal judge over unsanitary conditions. Neptune Manufacturing Inc. can’t reopen until it meets compliance with the U.S. Food and Drug Administration....
  • Dropping coverage of popular prescription drugs is sad and shameful

    Express Scripts, which handles prescription-drug benefits for millions or people nationwide, is dropping coverage for 66 brand-name drugs next month in an effort to keep costs down. Rival CVS Health is dropping 95 drugs from its own list of covered drugs....
  • Karen Hicks: FDA should not approve sex drug for women

    There's yet another pharmaceutical campaign on the offensive, hoping to convince women with sexual problems that a drug called Flibanserin will cure them. This compound is a central nervous system formula originally studied as a remedy for depression....
  • Use these 4 simple strategies to cut your drug spending

    Trying to save money on prescription drugs can be enough to make you reach for the pain pills. Navigating the annual changes to your health plan, figuring out insurance co-pays, and finding the pharmacy with the best buys can be daunting. And if you're on...
  • Allergan is in merger talks with Irish pharmaceutical firm Actavis

    Allergan is in merger talks with Irish pharmaceutical firm Actavis
    Botox maker Allergan Inc. of Irvine, which has spent six months fighting a hostile takeover attempt by a Canadian company, is in increasingly serious discussions to merge with Irish pharmaceutical firm Actavis. If Allergan agrees to be acquired by...
  • Arrowhead Research seeks to reassure antsy investors

    Arrowhead Research seeks to reassure antsy investors
    Arrowhead Research Corp. is trying to succeed where major pharmaceutical company efforts have failed in finding a cure for one of the world's most tenacious diseases. The Pasadena biopharmaceutical company is developing so-called RNAi therapeutics. Such...
  • Local company develops training products for self-injection

    Local company develops training products for self-injection
    Twenty years ago Jeff Baker started a promotional product company in a spare bedroom in his home in Indianapolis. Today, that business, called Noble, has turned into a privately held multimillion-dollar niche product manufacturing company that takes...
  • Allergan sale to Actavis thwarts takeover attempt by Valeant

    Allergan sale to Actavis thwarts takeover attempt by Valeant
    Botox maker Allergan Inc., an Irvine company that started as a purveyor of eye drops and grew into one of the most respected pharmaceutical companies in the country, agreed to be acquired by Irish firm Actavis for $66 billion. The deal thwarts a...
  • Ingredion predicts $8 billion in sales by 2019

     Ingredion predicts $8 billion in sales by 2019
    Ingredion said Tuesday its annual sales should hit $8 billion by 2019, up from $6.33 billion last year, as the ingredients-maker pushes to notch more sales from fast-growing specialty products and international markets. The announcement comes weeks after...